We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Sareum Holdings Plc | LSE:SAR | London | Ordinary Share | GB00BMC3RJ87 | ORD GBP 0.0125 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 24.00 | 23.00 | 25.00 | 24.00 | 24.00 | 24.00 | 72,159 | 08:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 0 | -3.42M | -0.0317 | -7.57 | 25.91M |
| Date | Subject | Author | Discuss |
|---|---|---|---|
| 09/8/2024 08:21 | downward breakout, back to 10p. This pile of kaka been around for donkey years, dilution and consolidation, them more dilution then more consolidation. | ghost_walker | |
| 09/8/2024 07:44 | More news/data will be released in Q3 so hopefully before the end of next month. | z1co | |
| 09/8/2024 07:25 | £1 is coming # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # hahahahahahah | z1co | |
| 09/8/2024 07:24 | £1 is coming | z1co | |
| 09/8/2024 07:23 | £1 is coming | z1co | |
| 09/8/2024 07:22 | £1 >>>>> IS COMING IN Q3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .# # # # # # # # # # # # # # # # # # # # # # # # # | z1co | |
| 09/8/2024 07:14 | Aberystwyth8 Aug And you know this how Zico ? Wolfofwallstreets8 Aug '24 - 12:48 - 3 of 11 Thoth2 told him in a dream.. It's the licence deal that's been discussed for years.. As well as the takeover which has been expected for 20 years... Z1CO8 Aug '24 - 12:51 - 4 of 11 Aberystwyth I only know just as much as you but we'll see if these rumours do materialise over the next few quarters. | genghis_khan_ | |
| 09/8/2024 06:41 | From the latest rns: Dr John Reader, Chief Scientific Officer of Sareum, added: "The success of this stage of the clinical trial demonstrates that high blood levels of a dual TYK2/JAK1 kinase inhibitor can be achieved without serious side effects. Together with the long half-life observed, we believe this potentially gives SDC-1801 significant advantages over its competitors. We're grateful to the volunteers who participated in this trial, and to the clinical staff who enabled its timely completion." The Company expects that further data, unblinded from drug/placebo recipients, including details of any mild or moderate adverse events and biomarkers of TYK2 and/or JAK1 inhibition, will be available in Q3 2024. | z1co | |
| 09/8/2024 06:21 | The average one-year price target for Sareum Holdings plc is 179.52 GBX. The forecasts range from a low of 177.76 GBX to a high of 184.80 GBX. A stock's price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. | z1co | |
| 09/8/2024 06:12 | hahahaha . . . . . . . . hahahahah | z1co | |
| 09/8/2024 06:11 | hahahaha . | z1co | |
| 09/8/2024 06:04 | downward breakout, back to 10p. This pile of kaka been around for donkey years, dilution and consolidation, them more dilution then more consolidation. | genghis_khan_ |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
